These findings highlight the utility of TNFα and its downstream signalling pathways as important drug targets for pain relief in gastrointestinal diseases, such as IBS and IBD, in which enhanced TNFα expression has been reported. The gene discussed is TNF; the disease is irritable bowel syndrome.